Camber Capital Management LP Jazz Pharmaceuticals PLC Transaction History
Camber Capital Management LP
- $4.32 Billion
- Q4 2024
A detailed history of Camber Capital Management LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Camber Capital Management LP holds 1,150,000 shares of JAZZ stock, worth $159 Million. This represents 3.28% of its overall portfolio holdings.
Number of Shares
1,150,000
Previous 1,150,000
-0.0%
Holding current value
$159 Million
Previous $128 Million
10.54%
% of portfolio
3.28%
Previous 4.07%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$848 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$833 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$349 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$306 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$281 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.65B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...